Clinical Trials Directory

Trials / Completed

CompletedNCT03308643

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effects of oxytocin infusion during abdominal myomectomy.

Detailed description

Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20% of the abdominal myomectomy cases might require blood transfusion because of the nature of the surgery. Oxytocin infusion is one of the intervention to decrease blood loss during myomectomy. To evaluate the effects and benefits of oxytocin infusion during abdominal myomectomy we decide to conduct this randomized study.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinPatients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.
OTHERsalinePatients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia.

Timeline

Start date
2017-10-01
Primary completion
2018-05-10
Completion
2018-05-10
First posted
2017-10-12
Last updated
2018-05-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03308643. Inclusion in this directory is not an endorsement.

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy (NCT03308643) · Clinical Trials Directory